Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Leading Life Sciences IP Litigation Group Joins Morrison Foerster in New York


News provided by

Morrison Foerster

Aug 01, 2024, 11:00 ET

Share this article

Share toX

Share this article

Share toX

IP Litigation partners Bindu Donovan, Todd Krause, and Alyssa Monsen bring over 60 years of experience litigating complex, high-stakes patent cases across the life sciences industry

NEW YORK, Aug. 1, 2024 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrivals of Bindu Donovan, Todd Krause, and Alyssa Monsen as partners in the firm's market-leading IP Litigation Group, based in the New York office. Donovan, Krause, and Monsen bring more than six decades of combined experience litigating high-stakes IP matters in the life sciences sector.

The group joins Morrison Foerster from a New York-based IP litigation firm. Donovan has over 25 years of experience litigating high-stakes intellectual property disputes in the life sciences sector. Focusing on patent litigation in U.S. federal courts, Donovan has represented clients across a wide range of life sciences matters, including biologics, small-molecule drugs, and medical devices. Krause, who holds a Ph.D. in Biological Sciences, also brings more than 25 years of experience successfully litigating patent cases for some of the world's largest pharmaceutical and biotechnology companies. He has litigated matters across the life sciences, including small-molecule drugs, biologic drugs, medical devices, gene amplification techniques, cell-based assays, vaccines, and recombinant nucleic acids and proteins. Monsen brings over a decade of experience and focuses her practice on life sciences patent litigation in a variety of technologies, including small molecules and biologics, in federal district and appellate courts and inter partes review proceedings before the Patent Trial and Appeal Board.

"We are thrilled to welcome Bindu, Todd, and Alyssa to the firm," said Morrison Foerster partner Daralyn Durie. "The addition of this highly experienced team will expand our capabilities in the strategic Northeast region, home to many of the largest life sciences companies. And as life sciences patent litigation continues to proliferate worldwide, Bindu, Todd, and Alyssa will bolster MoFo's well-established reputation as the firm to turn to when bet-the-company life sciences patent cases arise. Our clients will benefit from their decades of experience, strong technical backgrounds, and advanced scientific degrees as we continue to build strength upon strength in our top-tier global IP Litigation practice."

Representing a roster of top industry clients, the team has secured significant wins across a range of high-profile matters. Collectively, they have litigated a wide array of biologic and pharmaceutical therapies, advised major pharmaceutical clients on offensive and defensive litigation strategies, and led clients through successful licensing campaigns. Krause, Donovan, and Monsen also have significant and recognized experience representing innovator companies in Hatch Waxman litigation.

"We are excited to join MoFo's powerhouse IP Litigation practice and Life Sciences + Healthcare industry team, and look forward to leveraging our strong connections and collective experience to grow MoFo's presence in the critical Northeast market and beyond," said Donovan.
"Innovators and branded companies, facing an increasingly complex legal and scientific landscape, need sophisticated counsel to help them protect their ideas and products. Working collaboratively with MoFo's preeminent Life Sciences + Healthcare industry team across the firm's global offices will allow us to serve our clients wherever their issues arise in a fully integrated way." added Krause.

Monsen agreed, stating "MoFo's reputation as a destination life sciences trial practice, its collaborative culture, and its deep understanding of the life sciences industry set it apart from other firms. We are thrilled to join this premier trial practice."

Benchmark Litigation has ranked Donovan as one of the Top 250 Women in Litigation and a Local Litigation Star; Managing Intellectual Property has recognized her as an IP Star and one of the Top 250 Women in IP; Best Lawyers has recognized her in Litigation - Intellectual Property; and IAM Patent 1000 named her a Leading IP Litigation Lawyer. Krause has been recognized by LMG Life Sciences as a Hatch-Waxman Patent Litigation Star, by Managing Intellectual Property as an IP Star, and is recommended by IAM Patent 1000. Monsen was recently named a New York Rising Star in Intellectual Property Litigation by Super Lawyers magazine and recognized by Best Lawyers as Ones to Watch in both Intellectual Property Litigation and Patent Litigation.

Donovan earned her B.S. in Biology from York University, her M.S. in Biology from Western University, and her J.D. from Fordham University School of Law. She is admitted to practice in New York. Krause earned his B.A. in Economics from Trinity University, his Ph.D. in Biological Sciences (Neuroscience) from the University of Texas at Austin, and his J.D., cum laude, from University of Houston Law Center. He is admitted to practice in New York and is registered to practice before the U.S. Patent and Trademark Office. Monsen earned her B.A. in Molecular Biology from Princeton University and her J.D. from Georgetown University Law Center, where she received the CALI Award for Tort Law. She is admitted to practice in New York.

About Morrison Foerster

Morrison Foerster is a leading global law firm that transforms complexity into advantage for its clients. Our clients include some of the largest financial institutions, banks, consulting and accounting firms, and Fortune 100, technology, and life sciences companies. Highlighting the firm's commitment to client service, leadership in market-changing deals and impact litigation, and values-based culture, Morrison Foerster has been named to The American Lawyer's A-List for 20 of the ranking's 21 years. Year after year, the firm receives significant recognition from Chambers and The Legal 500 across their various guides, including Global, USA, Asia Pacific, Europe, UK, Latin America, and FinTech Legal. Our lawyers passionately care about delivering legal excellence while living our values. Morrison Foerster has a longstanding commitment to creating a culture that respects and celebrates differences, while providing an inclusive environment. The firm has achieved Mansfield Certification Plus since 2018 as a result of having at least 30 percent women, minority, LGBTQ+, and lawyers with disabilities representation across notable leadership roles and within the partnership. In addition, the firm was selected as the "Outstanding Firm for Diversity & Inclusion" as part of the Chambers Diversity & Inclusion Awards: USA 2023. Morrison Foerster also has a long history of commitment to the community and society through providing pro bono legal services, including litigating for civil rights and civil liberties, improving public education and fostering the wellbeing of children, advocating for veterans, promoting international human rights, enforcing the right to asylum, and safeguarding the environment. For more information, visit http://www.mofo.com.

Media Contact

Carla Del Bove, Morrison Foerster, (617) 648-4745, [email protected], mofo.com 

SOURCE Morrison Foerster

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.